Key opportunities in the iPSC market include focusing on fibroblasts and hepatocytes for cell type growth, expanding drug ...
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, cardiometabolic diseases and GI oncological therapeutics, announced today ...
CNW/ - MNP today announced it has been named a finalist for the Low-Code Application Development 2025 Microsoft Partner of the Year Award. The firm's ...
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer .
Google is taking its no-code AI app builder, Opal, global by expanding to more than 160 countries. The tool lets anyone build AI-powered mini-apps using plain language instead of programming. From ...
In the past six months, Turbo AI, a notetaking app founded by 20-year-olds that targets students, has grown from 1 million ...